IP Library Granted Patent US 11,389,088
Granted Patent B2
US 11,389,088 · App. 16/035,230 · Granted Jul 19, 2022

Multi-scale display of blood glucose information

Inventors: Lane Desborough (Thousand Oaks, CA); Bryan Mazlish (Palo Alto, CA); Sabine Kabel-Eckes (Mountain View, CA); Jeff Boissier (San Jose, CA)
Assignee: Bigfoot Biomedical, Inc.
A61B5/14532A61B5/4839A61B5/6898A61B5/744A61B5/7435A61M5/003A61M5/14244A61M5/14248A61M5/1723G16H20/13G16H40/63A61B5/0002A61B5/4836A61B5/7275A61M2005/14272A61M2005/14296A61M2205/505A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,389,088
App. No.
16/035,230
Granted
Jul 19, 2022
Kind
B2
Abstract

A method of displaying blood glucose information may include monitoring blood glucose levels of a user, where the blood glucose levels include at least a current blood glucose level and a historic blood glucose level. The method may also include presenting the current blood glucose level using a point indicator along an approximately horizontally centered axis based on a non-linear scale, and presenting the historic blood glucose level and a predicted future blood glucose level on the display as a single smoothed curve passing the point indicator.

Claims (35)

1. A method of displaying blood glucose information, the method comprising:

monitoring blood glucose levels of a user, the blood glucose levels including at least a current blood glucose level and a historic blood glucose level;

presenting the current blood glucose level using a point indicator centered on a horizontal axis, wherein the point indicator is displayed according to a non-linear vertical scale of blood glucose levels; and

presenting the historic blood glucose level and a predicted future blood glucose level on a display as a single smoothed curve passing through the point indicator, wherein the historic blood glucose level and the predicted future blood glucose level are displayed according to a linear vertical scale of blood glucose levels.

2. The method of claim 1 , wherein the display includes a first color above the single smoothed curve and a different second color below the single smoothed curve.

3. The method of claim 2 , changing the first color, the different second color, or both based on the current blood glucose level.

4. The method of claim 1 , wherein the linear vertical scale of blood glucose values is anchored on the display based on the current blood glucose level plotted on the non-linear vertical scale of blood glucose values.

5. The method of claim 1 , wherein the single smoothed curve provides a non-numerical representation of the predicted future blood glucose level.

6. The method of claim 1 , predicting a future blood glucose level using a predictive algorithm that uses insulin delivery and/or food consumption data.

7. The method of claim 6 , wherein the predictive algorithm assumes a future basal insulin delivery that is adjusted based on a closed-loop insulin delivery algorithm.

8. The method of claim 1 , wherein the smoothed curve and/or the point indicator provide an approximation of the predicted future blood glucose level.

9. The method of claim 1 , further comprising:

presenting a blood glucose level representation that corresponds to the non-linear vertical scale of blood glucose levels, and

wherein the presented predicted future blood glucose level is presented relative to the blood glucose level representation.

10. The method of claim 9 , wherein the blood glucose level representation comprises one or more of numerical representations of blood glucose levels and non-numerical representations of blood glucose levels.

11. The method of claim 10 , wherein the blood glucose level representation comprises at least one region defined by a first numerical representation of a blood glucose level and a second numerical representation of a blood glucose level, and at least part of the presented predicted future blood glucose level corresponds to the at least one region.

12. A device for displaying blood glucose information, comprising:

a display;

one or more processors; and

a non-transitory computer-readable medium containing instructions that, when executed by the one or more processors, cause the device to perform operations, the operations comprising:

monitoring blood glucose levels of a user, the blood glucose levels including at least a current blood glucose level and a historic blood glucose level;

presenting the current blood glucose level using a point indicator centered on a horizontal axis, wherein the point indicator is displayed according to a non-linear vertical scale of blood glucose levels; and

presenting the historic blood glucose level and a predicted future blood glucose level on the display as a single smoothed curve passing through the point indicator wherein the historic blood glucose level and the predicted future blood glucose level are displayed according to a linear vertical scale of blood glucose levels.

13. The device of claim 12 , wherein the display includes a first color above the single smoothed curve and a different second color below the single smoothed curve.

14. The device of claim 13 , wherein the operations further comprise changing the first color, the different second color, or both based on the current blood glucose level.

15. The device of claim 12 , wherein the linear vertical scale of blood glucose values is anchored on the display based on the current blood glucose level plotted on the non-linear vertical scale of blood glucose values.

16. The device of claim 12 , wherein the single smoothed curve is configured to provide a non-numerical representation of the predicted future blood glucose level.

17. The device of claim 12 , wherein the operations further comprise predicting a future blood glucose level using a predictive algorithm that uses insulin delivery and/or food consumption data.

18. The device of claim 17 , wherein the predictive algorithm assumes a future basal insulin delivery that is adjusted based on a closed-loop insulin delivery algorithm.

19. The device of claim 12 , wherein the smoothed curve and/or the point indicator provide an approximation of the predicted future blood glucose level.

20. The device of claim 12 , wherein the operations further comprise:

presenting a blood glucose level representation that corresponds to the non-linear vertical scale of blood glucose levels, and

wherein the presented predicted future blood glucose level is presented relative to the blood glucose level representation.

21. The device of claim 20 , wherein the blood glucose level representation comprises one or more of numerical representations of blood glucose levels and non-numerical representations of blood glucose levels.

22. The device of claim 21 , wherein the blood glucose level representation comprises at least one region defined by a first numerical representation of a blood glucose level and a second numerical representation of a blood glucose level, and at least part of the presented predicted future blood glucose level corresponds to the at least one region.

Assignments (19)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069870/0588 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069071/0980 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
RELEASE OF SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069030/0157 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 069019/0346 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 068948/0377 →
RELEASE OF SECURITY INTEREST Recorded Sep 26, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 065029/0271 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2018
From: DESBOROUGH, LANE; MAZLISH, BRYAN; KABEL-ECKES, SABINE; BOISSIER, JEFF
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 047073/0393 →
Cited By (8)
US 1,068,516 US 1,083,640 US 1,083,977 US 1,083,980 US 1,122,264 US 1,122,942 US 1,137,686 US 12,653,426